Published 21 July 2003. doi:10.1084/jem.20021279
© Rockefeller University Press,
0022-1007/2003/7/341 $5.00
The Journal of Experimental Medicine, Volume 198, Number 2, 341-347
XIAP-mediated Caspase Inhibition in Hodgkin's Lymphomaderived B Cells
Hamid Kashkar1,
Christiane Haefs1,
Hwain Shin2,
Stephen J. Hamilton-Dutoit3,
Guy S. Salvesen2,
Martin Krönke1 and
Juliane M. Jürgensmeier1
1 Institute for Medical Microbiology, Immunology, and Hygiene, University of Cologne, 50935 Köln, Germany
2 The Burnham Institute, Program for Apoptosis and Cell Death Research, La Jolla, CA 92037
3 Institute of Pathology, Aarhus University Hospital, Komunehospitalet, 8000 Aarhus C, Denmark
Address correspondence to Martin Krönke, Institute for Medical Microbiology, Immunology and Hygiene, University of Cologne, Goldenfelsstrasse 19-21, 50935 Cologne, Germany. Phone: 49-221-478-3060; Fax: 49-221-478-3067; E-mail: martin.kroenke{at}medizin.uni-koeln.de
The malignant Hodgkin and Reed-Sternberg cells of Hodgkin's lymphoma (HL) and HL-derived B cell lines were previously shown to be resistant to different apoptotic stimuli. We show here that cytochrome c fails to stimulate caspases-9 and -3 activation in cytosolic extracts of HL-derived B cells, which is due to high level expression of X-linked inhibitor of apoptosis (XIAP). Coimmunoprecipitation studies revealed that XIAP, apoptosis protease-activating factor1, and caspase-3 are complexed in HL-derived B cell lysates. Even after stimulation with exogenous cytochrome c and dATP, XIAP impairs the proteolytic processing and activation of caspase-3. In cytosolic extracts, inhibition of XIAP by the second mitochondria-derived activator of caspases (Smac)/DIABLO, or immunodepletion of XIAP restores cytochrome ctriggered processing and activation of caspase-3. Smac or a Smac-derived agonistic peptide also sensitized intact HL-derived B cells for the apoptotic action of staurosporine. Finally, Hodgkin and Reed-Sternberg cells of primary tumor HL tissues also constitutively and abundantly express XIAP. The results of this paper suggest that high level XIAP expression is a hallmark of HL, which may play a crucial role in resistance to apoptosis.
Key Words: cancer tumor apoptosis mitochondria Smac/DIABLO

CiteULike
Complore
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
-
Boll, B., Eltaib, F., Reiners, K. S., von Tresckow, B., Tawadros, S., Simhadri, V. R., Burrows, F. J., Lundgren, K., Hansen, H. P., Engert, A., Pogge von Strandmann, E.
(2009). Heat Shock Protein 90 Inhibitor BIIB021 (CNF2024) Depletes NF-{kappa}B and Sensitizes Hodgkin's Lymphoma Cells for Natural Killer Cell-Mediated Cytotoxicity. Clin. Cancer Res.
15: 5108-5116
[Abstract]
[Full Text]
-
Kapatai, G, Murray, P
(2007). Contribution of the Epstein Barr virus to the molecular pathogenesis of Hodgkin lymphoma. J. Clin. Pathol.
60: 1342-1349
[Abstract]
[Full Text]
-
Seligson, D. B., Hongo, F., Huerta-Yepez, S., Mizutani, Y., Miki, T., Yu, H., Horvath, S., Chia, D., Goodglick, L., Bonavida, B.
(2007). Expression of X-Linked Inhibitor of Apoptosis Protein Is a Strong Predictor of Human Prostate Cancer Recurrence. Clin. Cancer Res.
13: 6056-6063
[Abstract]
[Full Text]
-
Kashkar, H., Deggerich, A., Seeger, J.-M., Yazdanpanah, B., Wiegmann, K., Haubert, D., Pongratz, C., Kronke, M.
(2007). NF-{kappa}B-independent down-regulation of XIAP by bortezomib sensitizes HL B cells against cytotoxic drugs. Blood
109: 3982-3988
[Abstract]
[Full Text]
-
Abdullah, Z., Saric, T., Kashkar, H., Baschuk, N., Yazdanpanah, B., Fleischmann, B. K., Hescheler, J., Kronke, M., Utermohlen, O.
(2007). Serpin-6 Expression Protects Embryonic Stem Cells from Lysis by Antigen-Specific CTL. J. Immunol.
178: 3390-3399
[Abstract]
[Full Text]
-
Kashkar, H., Seeger, J.-M., Hombach, A., Deggerich, A., Yazdanpanah, B., Utermohlen, O., Heimlich, G., Abken, H., Kronke, M.
(2006). XIAP targeting sensitizes Hodgkin lymphoma cells for cytolytic T-cell attack. Blood
108: 3434-3440
[Abstract]
[Full Text]
-
Thomas, R. K., Sos, M. L., Zander, T., Mani, O., Popov, A., Berenbrinker, D., Smola-Hess, S., Schultze, J. L., Wolf, J.
(2005). Inhibition of Nuclear Translocation of Nuclear Factor-{kappa}B Despite Lack of Functional I{kappa}B{alpha} Protein Overcomes Multiple Defects in Apoptosis Signaling in Human B-Cell Malignancies. Clin. Cancer Res.
11: 8186-8194
[Abstract]
[Full Text]
-
Re, D., Kuppers, R., Diehl, V.
(2005). Molecular Pathogenesis of Hodgkin's Lymphoma. JCO
23: 6379-6386
[Abstract]
[Full Text]
-
Re, D., Thomas, R. K., Behringer, K., Diehl, V.
(2005). From Hodgkin disease to Hodgkin lymphoma: biologic insights and therapeutic potential. Blood
105: 4553-4560
[Abstract]
[Full Text]
-
Sun, Y., Orrenius, S., Pervaiz, S., Fadeel, B.
(2005). Plasma membrane sequestration of apoptotic protease-activating factor-1 in human B-lymphoma cells: a novel mechanism of chemoresistance. Blood
105: 4070-4077
[Abstract]
[Full Text]
-
Muris, J. J. F., Cillessen, S. A. G. M., Vos, W., van Houdt, I. S., Kummer, J. A., van Krieken, J. H. J. M., Jiwa, N. M., Jansen, P. M., Kluin-Nelemans, H. C., Ossenkoppele, G. J., Gundy, C., Meijer, C. J. L. M., Oudejans, J. J.
(2005). Immunohistochemical profiling of caspase signaling pathways predicts clinical response to chemotherapy in primary nodal diffuse large B-cell lymphomas. Blood
105: 2916-2923
[Abstract]
[Full Text]
-
Liu, H., Ma, Y., Pagliari, L. J., Perlman, H., Yu, C., Lin, A., Pope, R. M.
(2004). TNF-{alpha}-Induced Apoptosis of Macrophages Following Inhibition of NF-{kappa}B: A Central Role for Disruption of Mitochondria. J. Immunol.
172: 1907-1915
[Abstract]
[Full Text]